CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Option exercise | +8,876 | $9.59 | $85K | 117,757 |
| 2025-12-12 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | −4,692 | $230.76 | $1.1M | 113,065 |
| 2025-12-12 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Option exercise | +13,500 | $9.59 | $129K | 126,565 |
| 2025-12-12 | ROSENMAN HERM Director | Sale | −14,372 | $226.62 | $3.3M | 54,389 |
| 2025-12-12 | ROSENMAN HERM Director | Sale | −21,910 | $227.35 | $5.0M | 32,479 |
| 2025-12-12 | ROSENMAN HERM Director | Sale | −11,987 | $228.49 | $2.7M | 20,492 |
| 2025-12-12 | ROSENMAN HERM Director | Sale | −150 | $229.10 | $34K | 20,342 |
| 2025-12-10 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Option exercise · Stock Option (right to buy) | −22,376 | 5,125 | ||
| 2025-12-09 | Sheena Jonathan Director | Option exercise | +4,436 | $9.29 | $41K | 227,096 |
| 2025-12-09 | Sheena Jonathan Director | Option exercise · Stock Option (right to buy) | −4,436 | 5,544 | ||
| 2025-12-05 | Chapman Rowan E Director | Option exercise | +4,000 | $32.15 | $129K | 10,143 |
| 2025-12-05 | Chapman Rowan E Director | Sale | −4,000 | $243.08 | $972K | 6,143 |
| 2025-12-05 | Chapman Rowan E Director | Sale | −366 | $243.39 | $89K | 5,777 |
| 2025-12-05 | Chapman Rowan E Director | Option exercise · Stock Option (right to buy) | −4,000 | 7,000 | ||
| 2025-12-04 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise | +6,902 | $19.68 | $136K | 208,601 |
| 2025-12-04 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Stock Option (Right to Buy) | −6,902 | 5,598 | ||
| 2025-12-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −749 | $237.23 | $178K | 111,312 |
| 2025-12-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −250 | $237.77 | $59K | 111,062 |
| 2025-12-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,527 | $238.24 | $364K | 109,535 |
| 2025-12-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −474 | $239.53 | $114K | 109,061 |
Page 31 of 39 · 767 trades